痤瘡治療市場規模、佔有率和成長分析（按產品、給藥途徑、年齡層、分銷管道和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，痤瘡治療市場規模將達到 122.1 億美元，到 2025 年將達到 128.3 億美元，到 2033 年將達到 191 億美元，預測期（2026-2033 年）的複合年成長率為 5.1%。

全球痤瘡治療市場的成長主要受痤瘡盛行率上升的驅動，尤其是在青少年和成人群體中。痤瘡是一種常見的皮膚疾病，影響全球約9.4%的人口，因此，人們對抗生素和類視色素等有效治療方法的需求日益成長。推動這一成長的因素包括久坐生活方式的增加、不良的飲食習慣以及對微創美容手術的偏好日益增強。此外，人們對痤瘡治療安全性的擔憂也對市場擴張構成挑戰。研究表明，遺傳因素、壓力、荷爾蒙變化、氣候和化妝品使用等多種因素都會影響痤瘡的嚴重程度，凸顯了個人化治療方案的必要性。這種動態變化的環境持續影響消費者的偏好，並推動痤瘡治療領域的創新。

痤瘡治療市場細分分析

痤瘡治療市場成長要素

全球皮膚疾病盛行率的不斷上升是痤瘡治療市場成長的主要驅動力。隨著越來越多的人尋求痤瘡解決方案，尤其是在北美、歐洲和亞太地區，患者對有效治療方法，例如類視色素、異維A酸以及口服和外用抗生素，提高了人們對現有產品和治療方案的認知。因此，隨著患者對各種可用治療方法的了解不斷加深，預計該市場將繼續快速擴張。

制約痤瘡治療市場的因素

儘管慢性痤瘡十分普遍，但痤瘡治療市場的發展仍面臨許多挑戰。抗生素治療的副作用，例如噁心、嘔吐和腹瀉，會影響相當一部分患者，引發了對抗生素使用的擔憂。此外，監管機構已發布警告，指出某些非處方藥可能有引發嚴重過敏反應和皮膚刺激的風險。這些安全隱患不僅削弱了消費者的信心，也限制了治療選擇，嚴重阻礙了市場上有效痤瘡治療方法的發展。這些因素共同限制了該行業的成長。

痤瘡治療市場趨勢

痤瘡治療市場正經歷著向微創療法的顯著轉變，這主要得益於意識提升以及對非侵入性治療方案（而非傳統手術）的偏好。皮膚科醫生擴大推薦局部用藥和聯合治療，這些療法在有效緩解不適的同時，也能帶來顯著療效。醫病溝通的加強和完善的治療通訊協定推動了這一趨勢，鼓勵患者積極尋求皮膚問題的解決方案。由此產生的需求推動了對創新、無痛且療效顯著的痤瘡治療的需求，這也反映了皮膚科領域以患者為中心的綜合治療模式的更廣泛市場趨勢。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 一手和二手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 用例
• 監管環境
• 客戶和購買標準分析
• Start-Ups分析
• 專利分析

全球痤瘡治療市場規模（按產品分類）及複合年成長率（2026-2033 年）

• 類視色素
• 抗生素
• 異維A酸
• 其他

全球痤瘡治療市場規模（按給藥途徑和複合年成長率分類）（2026-2033 年）

• 口服
• 外用

全球痤瘡治療市場規模（按年齡層別分類）及複合年成長率（2026-2033 年）

• 10至17歲
• 18至44歲
• 45至64歲
• 65歲或以上

全球痤瘡治療市場規模（按分銷管道分類）及複合年成長率（2026-2033 年）

• 醫院藥房
• 零售藥房
• 網路藥房

全球痤瘡治療市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

  主要企業簡介

  • Ortho Dermatologics（博士倫健康公司）（美國）
  • 葛蘭素史克有限公司（英國）
  • 拜耳股份公司（德國）
  • 強生服務公司（美國）
  • 輝瑞公司（美國）
  • 艾伯維公司（美國）
  • 梯瓦製藥工業股份有限公司（以色列）
  • Botanix Pharmaceuticals（澳洲）
  • 歐萊雅集團（法國）
  • 倩碧實驗室有限公司（美國）
  • 露得清（美國）
  • Ancalima Lifesciences Ltd.（印度）
  • Guthy-Renker（美國）
  • Murad公司（美國）
  • 高絲株式會社（日本）
  • 雀巢皮膚健康（瑞士）
  • 太陽製藥工業有限公司（印度）
  • 邁蘭公司（美國）

結論與建議

Acne Treatment Market size was valued at USD 12.21 Billion in 2024 and is poised to grow from USD 12.83 Billion in 2025 to USD 19.1 Billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The global acne treatment market is driven by the increasing prevalence of acne, particularly among adolescents and adults. As a widespread skin condition affecting approximately 9.4% of the global population, there is notable demand for effective treatment options such as antibiotics and retinoids. Factors contributing to this growth include rising sedentary lifestyles, poor dietary habits, and a growing preference for minimally invasive cosmetic procedures. Additionally, safety concerns regarding acne treatment medications pose challenges to market expansion. Research indicates that various elements, including genetics, stress, hormonal changes, climate, and cosmetic use, influence acne severity, highlighting the need for tailored treatment solutions. This dynamic environment continues to shape consumer preferences and drive innovation in the acne treatment sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Acne Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Acne Treatment Market Segments Analysis

Global Acne Treatment Market is segmented by Product, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Retinoids, Antibiotics, Isotretinoin and Others. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Acne Treatment Market

The increasing prevalence of skin disorders globally is significantly driving growth in the acne treatment market. As more individuals seek solutions for their acne issues, particularly in regions like North America, Europe, and the Asia Pacific, there is a notable surge in patient demand for effective treatments. The introduction of a variety of acne therapies, including retinoids, isotretinoin, and both oral and topical antibiotics, is enhancing awareness of available products and treatment options. Consequently, as patients become more informed about the different types of therapies accessible to them, the market is anticipated to continue expanding rapidly.

Restraints in the Acne Treatment Market

The growth of the acne treatment market faces several challenges despite the widespread occurrence of chronic acne. Adverse side effects associated with antibiotic treatments, such as nausea, vomiting, and diarrhea, can affect a notable percentage of patients, raising concerns about their use. Additionally, regulatory bodies have issued warnings regarding certain over-the-counter medications that carry risks of severe allergic reactions or intense irritation. These safety concerns not only diminish consumer confidence but also limit treatment options, thus creating significant obstacles for the advancement of effective acne therapies within the market. The combined effect of these factors contributes to constraints in industry growth.

Market Trends of the Acne Treatment Market

The Acne Treatment market is witnessing a significant shift towards minimally invasive therapies, fueled by increasing consumer awareness and a preference for less invasive options over traditional surgical procedures. Dermatologists are increasingly favoring topical agents and combination treatments that offer effective results with reduced discomfort. Enhanced patient-physician communication and well-established treatment protocols contribute to this trend, encouraging patients to seek proactive solutions for skin disorders. As a result, there is a growing demand for innovative, less painful acne treatments that deliver visible results, reflecting a broader market movement towards holistic and patient-centric care in dermatology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Startup Analysis
• Patent Analysis

Global Acne Treatment Market Size by Product & CAGR (2026-2033)

• Market Overview
• Retinoids
• Antibiotics
• Isotretinoin
• Others

Global Acne Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Topical

Global Acne Treatment Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• 10 to 17 Years
• 18 to 44 Years
• 45 to 64 Years
• 65 Years & Above

Global Acne Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Acne Treatment Market Size & CAGR (2026-2033)

• North America (Product, Route of Administration, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Product, Route of Administration, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Ortho Dermatologics (Bausch Health Companies Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Botanix Pharmaceuticals (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L'Oreal S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinique Laboratories, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neutrogena (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ancalima Lifesciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guthy-Renker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Murad, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kose Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Skin Health (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations